HK1119569A1 - Lipidated tissue factor for use as topical antihemorrhagic agent - Google Patents

Lipidated tissue factor for use as topical antihemorrhagic agent

Info

Publication number
HK1119569A1
HK1119569A1 HK08111596.7A HK08111596A HK1119569A1 HK 1119569 A1 HK1119569 A1 HK 1119569A1 HK 08111596 A HK08111596 A HK 08111596A HK 1119569 A1 HK1119569 A1 HK 1119569A1
Authority
HK
Hong Kong
Prior art keywords
tissue factor
lipidated tissue
antihemorrhagic agent
topical
topical antihemorrhagic
Prior art date
Application number
HK08111596.7A
Other languages
English (en)
Chinese (zh)
Inventor
Egea Javier Pedreo
Catass Luis Caveda
Original Assignee
斯洛柏塔蓋茲歐洲有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 斯洛柏塔蓋茲歐洲有限公司 filed Critical 斯洛柏塔蓋茲歐洲有限公司
Publication of HK1119569A1 publication Critical patent/HK1119569A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK08111596.7A 2005-08-03 2008-10-21 Lipidated tissue factor for use as topical antihemorrhagic agent HK1119569A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05380179A EP1749536A1 (fr) 2005-08-03 2005-08-03 Stimulateurs activés du Facteur X et leur utilisation en tant qu'agents anti-hemorragiques pour l'usage topique
PCT/EP2006/007660 WO2007014771A1 (fr) 2005-08-03 2006-08-02 Stimulateurs de facteur x active (fxa) utilises en tant que nouveaux agents antihemorragiques topiques

Publications (1)

Publication Number Publication Date
HK1119569A1 true HK1119569A1 (en) 2009-03-13

Family

ID=35916272

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08111596.7A HK1119569A1 (en) 2005-08-03 2008-10-21 Lipidated tissue factor for use as topical antihemorrhagic agent

Country Status (13)

Country Link
EP (3) EP1749536A1 (fr)
JP (2) JP2009503009A (fr)
KR (1) KR101362993B1 (fr)
CN (1) CN101291686B (fr)
AU (1) AU2006274979B2 (fr)
BR (1) BRPI0616535B8 (fr)
CA (1) CA2617534C (fr)
DK (1) DK1917026T3 (fr)
ES (1) ES2468225T3 (fr)
HK (1) HK1119569A1 (fr)
PL (1) PL1917026T3 (fr)
TW (2) TWI441645B (fr)
WO (2) WO2007014771A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772371B2 (en) * 2005-08-03 2010-08-10 Thrombotargets Corporation Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents
EP2745852A1 (fr) * 2012-12-21 2014-06-25 Thrombotargets Europe, S.L. Compositions d'agent d'étanchéité
EP2759305A1 (fr) * 2013-01-24 2014-07-30 Thrombotargets Europe, S.L. Compositions hémostatiques
CN110133303B (zh) * 2019-05-13 2023-04-07 深圳优迪生物技术有限公司 凝血酶原时间测定试剂及其应用
CN112433057B (zh) * 2020-11-10 2023-06-09 北京美创新跃医疗器械有限公司 一种狼疮抗凝物的筛选试剂及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721618A (en) * 1983-06-27 1988-01-26 Queen's University At Kingston Method for controlling bleeding
EP0266993B1 (fr) 1986-11-04 1995-04-05 Genentech, Inc. Méthode et compositions thérapeutiques pour le traitement de désordres de la coagulation
US5017556A (en) * 1986-11-04 1991-05-21 Genentech, Inc. Treatment of bleeding disorders using lipid-free tissue factor protein
US6239101B1 (en) * 1989-07-05 2001-05-29 Oklahoma Medical Research Foundation Thrombin binding polypeptides
US6238875B1 (en) * 1991-03-12 2001-05-29 The Scripps Research Institute Diagnostic methods useful in the characterization of lymphoproliferative disease characterized by increased EPR-1
WO1993009804A1 (fr) * 1991-11-18 1993-05-27 The Scripps Research Institute Polypeptides derives de la serine protease et anticorps anti-peptidiques, systemes et procedes therapeutiques empechant la coagulation du sang
AU4784693A (en) * 1992-07-24 1994-02-14 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
US5441759A (en) * 1992-09-03 1995-08-15 Sherwood Medical Company Method to stabilize TDMAC heparin coating
CA2223491C (fr) * 1995-06-07 2010-08-10 Ortho Pharmaceutical Corporation Anticorps contre la thromboplastine tissulaire comportant des regions de determination complementaire greffees et leurs methodes d'utilisation
WO2000004148A1 (fr) * 1998-07-15 2000-01-27 Genentech, Inc. Variantes de proteines de facteurs tissulaires presentant une affinite accrue pour le facteur de coagulation fvii/fviia
ATE329263T1 (de) * 1998-10-30 2006-06-15 Jonathan L Miller Regionen variabler schwerer ketten und variabler leichter ketten von antikörpern für humanes blutplättchen-glykoprotein ib alpha
AU2002211686A1 (en) 2000-10-13 2002-04-22 On Site Gas Systems, Inc. Bandage using molecular sieves
US7015193B2 (en) * 2001-04-20 2006-03-21 University Of Vermont Compositions and methods to control bleeding
TWI338009B (en) * 2001-10-29 2011-03-01 Genentech Inc Antibodies for inhibiting blood coagulation and methods of use thereof
WO2004039842A2 (fr) * 2002-10-31 2004-05-13 Novo Nordisk A/S Anticorps humanises anti-facteur tissulaire
CA2570566A1 (fr) * 2004-06-25 2006-01-12 Altor Bioscience Corporation Production d'un facteur tissulaire chez des plantes

Also Published As

Publication number Publication date
ES2468225T9 (es) 2014-10-24
JP2009503008A (ja) 2009-01-29
EP1917026B1 (fr) 2014-03-05
EP1749536A1 (fr) 2007-02-07
KR20080043324A (ko) 2008-05-16
ES2468225T3 (es) 2014-06-16
WO2007014772A2 (fr) 2007-02-08
CA2617534C (fr) 2016-07-05
WO2007014771A1 (fr) 2007-02-08
EP1917026B9 (fr) 2014-06-18
CN101291686A (zh) 2008-10-22
CA2617534A1 (fr) 2007-02-08
WO2007014772A3 (fr) 2007-04-12
EP1915175A2 (fr) 2008-04-30
PL1917026T3 (pl) 2014-08-29
KR101362993B1 (ko) 2014-02-21
JP5268638B2 (ja) 2013-08-21
DK1917026T3 (da) 2014-06-10
AU2006274979B2 (en) 2012-12-13
EP1917026A1 (fr) 2008-05-07
TW200744628A (en) 2007-12-16
CN101291686B (zh) 2013-03-13
BRPI0616535A2 (pt) 2011-06-21
AU2006274979A1 (en) 2007-02-08
JP2009503009A (ja) 2009-01-29
TWI441645B (zh) 2014-06-21
TW200744633A (en) 2007-12-16
BRPI0616535B8 (pt) 2021-05-25
BRPI0616535B1 (pt) 2019-11-12

Similar Documents

Publication Publication Date Title
TWI366469B (en) Emulsified skin agent for external use
HUE054365T2 (hu) Bór-ftalidok terápiás alkalmazásra
ZA200708438B (en) External preparation for skin
HK1122991A1 (en) External preparation for skin
ZA200803150B (en) Topical Formulations
HK1115328A1 (en) Composition for treating skin lesions
GB2451597B (en) Compositions for topical treatment
EP1938808A4 (fr) Préparation à usage externe.
HK1119569A1 (en) Lipidated tissue factor for use as topical antihemorrhagic agent
EP1854354A4 (fr) Agent destine a ameliorer un pouvoir antiseptique
GB2416693B (en) Composition for reducing blood lipids
EP1957080A4 (fr) Formulations de glucocorticosteroide locales
EP1895843A4 (fr) Formules topiques de micogel
ZA200605597B (en) Compositions for use with skin
GB0516610D0 (en) Compounds for use in therapy
ZA201003835B (en) Therapeutic agent for ulcer
AU3435P (en) Kakegawa S63 Calibrachoa hybrid
AU3279P (en) USCALI11 Calibrachoa hybrid
AU3280P (en) USCALI4 Calibrachoa hybrid
AU3236P (en) Balcabrose Calibrachoa hybrid
AU3235P (en) Balcabwite Calibrachoa hybrid
AU3234P (en) Balcabcher Calibrachoa hybrid
AU3233P (en) Balcabpurp Calibrachoa hybrid
AU3281P (en) USCALI28 Calibrachoa hybrid
AU3238P (en) Balcabred Calibrachoa hybrid

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210807